Biosynthesis of 9-Methylstreptimidone Involves a New Decarboxylative Step for Polyketide Terminal Diene Formation.

Bo Wang,Yongxiang Song,Minghe Luo,Qi Chen,Junying Ma,Hongbo Huang,Jianhua Ju
DOI: https://doi.org/10.1021/ol400224n
IF: 5.2
2013-01-01
Organic Letters
Abstract:9-Methylstreptimidone is a glutarimide antibiotic showing antiviral, antifungal, and antitumor activities. Genome scanning, bioinformatics analysis, and gene inactivation experiments reveal a gene cluster responsible for the biosynthesis of 9-methylstreptimidone in Streptomyces himastatinicus. The unveiled machinery features both acyltransferase- and thioesterase-less iterative use of module 5 as well as a branching module for glutarimide generation. Impressively, inactivation of smdK leads to a new carboxylate analogue unveiling a new mechanism for polyketide terminal diene formation.
What problem does this paper attempt to address?